Why are switchable 2D-LC workflows fit for mAb manufacturing? Discover a practical AQbD approach for monitoring charge and size variants in one hour.
Lost material. Delayed production timelines. Reworks across teams.
If you’re working with monoclonal antibodies (mAbs) or other biopharmaceuticals, you already know the challenge: biological reactions are variable.
Unlike traditional small-molecule drugs, with simpler and more predictable chemical structures, biotherapeutics exist in a dynamic state of microheterogeneity — no two batches are ever truly identical.
Whether undergoing production, processing, or storage, these compounds often undergo unwanted side reactions like glycation, deamidation, charge variation, and aggregation, which can compromise product safety and efficacy.
Finding robust and dependable ways to monitor these critical quality attributes (CQA) and protect therapeutic integrity is even more pressing, as regulatory agencies demand comprehensive characterizations.
While analytical techniques like liquid chromatography (LC) and mass spectrometry (MS) play a fundamental role in CQA analysis, the increasing complexity of analytical tasks is forcing the requirements of instruments to grow.
The good news? Targeted two-dimensional LC (2D-LC) workflows that can handle analytical complexity and support straightforward method development without any manual fluidic changes are already here.
Let’s explore how your lab can use 2D-LC coupled with ultraviolet detection (UVD) or high-resolution accurate mass spectrometry (HRAM-MS) to monitor the CQAs of intact mAbs in real time (Figure 1).
Figure 1. Fluidic scheme of a 2D-LC-MS setup that supports multiple CQA analysis as well as method development without any manual replumbing.
Key takeaways:
- Why mAb variants matter
Physiochemical modifications generate diverse mAb variants — such as deamidated and aggregated species — that require monitoring to protect therapeutic efficacy and safety.
- What switchable 2D-LC brings you
Switchable heart-cut 2D-LC workflows allow direct upstream monitoring of multiple CQAs during the production cycle from cell culture samples.
- How the separation works
The mAb is purified from cell culture samples by protein A (ProA) affinity in the first dimension (1D). A high-performance strong cation exchange (SCX) column applied in the second dimension (2D) facilitates the separation of mAb charge variants or serves as a trap column to focus the purified mAb fraction prior to transfer to size exclusion chromatography (SEC).
- Speed vs. depth: choosing the right detector
UVD monitoring provides quick and simple trendlines, while the direct coupling of 2D with HRAM-MS allows deep characterizations and comprehensive insights into glycan profiles, modifications, and aggregates at the intact level.
- Why at-line monitoring matters
Near real-time analysis of bioreactor samples enables earlier intervention, helping control material costs, improve yield, reduce off-target variants, and avoid costly downtime from rework or restarting production.
How 2D-LC workflows help streamline mAb manufacturing and prevent costly issues
Near real-time monitoring enables early intervention of issues, helping maintain product cost and quality, protect yield, and more consistent downstream performance.
As best practice, you should begin monitoring product quality attributes (PQAs) from the start of the cell culture and continue daily throughout the process until your reaction reaches the target yield (Figure 2).
Figure 2. mAb titer calibration curve (left) and titer determination of cell culture samples from 1D ProA-UV (right). Samples were drawn from the bioreactors over 10 days.
For established reactions, you can track changes in titer, charge, or size variant profiles based on UV spectral patterns quickly adjust feeds or cell harvest timing to prevent further issues during downstream processing.
Trends like the formation of new shoulders, slight peak shifts, or loss in peak intensity often signal changes in media composition, nutrient availability, pH, or process stress (Figure 3).
For example:
- Emerging acidic or basic species may indicate chemical modifications, like glycation, deamidation, or other stress‑related changes.
- Size variants can reflect fragmentation or aggregation driven by temperature, agitation, or hold times.
Figure 3. 2D chromatogram of ProA-SCX-SEC analysis of harvested cell culture samples drawn on days 2 and 9.
Why switchable workflows provide a simpler path to fewer surprises, faster course corrections, and more consistent mAb production
Fortunately, you don’t need a complicated, manual multistep analysis pipeline to keep your mAb production schedule on track. A streamlined, switchable 2D-LC-UV-MS workflow gives you fast, actionable insights—straight from the bioreactor.
The setup includes a switchable fluidic design that lets you toggle between charge (SCX) and size variant analysis (SEC) without replumbing the hardware, providing complementary information.
This convenient approach combines cleanup and analysis in one system, eliminating manual sample preparation and enabling direct analysis of cell culture supernatants from the bioreactor (Figure 4).
Figure 4. Quality attribute monitoring of mAb biosynthesis by switchable 2D-LC-UV or MS workflow.
How switchable 2D-LC technology works:
- 1D. ProA affinity chromatography for titer determination and isolation of the mAb from host cell material and media components. The purified fraction is then sent via automated heart‑cut transfer straight into the 2D. The 1D elution conditions facilitate optimal mAb capture at the SCX column in the 2D.
- ProA‑SCX to see charge drifts. Gradient elution of the SCX column in the 2D to separate acidic and basic variants from the main peak.
- ProA‑SCX‑SEC to see aggregation risks. The SCX column is switched in line with the SEC column to resolve the monomer, low‑molecular‑weight (LMW), and high‑molecular‑weight (HMW) fractions. The SCX column here acts as a trap and refocusing stage, releasing the mAb into SEC in a narrow band by a step increase to high ionic strength. The trap/elute procedure is critical to yield sharp peaks downstream, as SEC cannot refocus bands, broadened by the loop volume.
Together, these workflows support both early risk detection and informed corrective action without adding analytical complexity.
UVD or MS? How to pick the right tool for the job
With switchable 2D-LC workflows, you can select different detection options in the 2D: UVD or HRAM-MS (Figure 5). The fluidic setups differ slightly, but you must always use a fully volatile buffer system with the MS option.
Here’s how to choose the right setup:
- UVD is ideal for routine, in‑time process control of established reactions. Provides quick and simple trendlines when you need clear thresholds to act on, as well as straightforward decisions when you need day-to-day control of established processes. Like the “traffic light” for your production.
- HRAM-MS is best when you need detailed native intact‑level confirmation, glycoform profiling, or deeper characterization of modifications during the development stage (Figure 5).
Figure 5. Coupling to UVD or HRAM MS in 2D charge variant analysis. Left: quick and straightforward batch comparison with the ProA-SCX-UV. Right: ProA-SCX-HRAM MS provides deep insights into glycoforms and modifications at the intact mass level
Operational benefits your entire team can trust
Real-time monitoring of mAb CQAs reveals when you need to intervene and implement a bioprocess change, protecting you from the most expensive surprises: scrap costs, poor yield, off-target product, and the downtime it takes to clean and start over.
From an operations perspective, the benefits of switchable 2D-LC workflows are clear and practical (Figure 6).
- A single system performs at-line cleanup and analysis, reducing manual handling and process variability.
- Heart-cut transfer minimizes sample loss and contamination risk, while the switchable design provides fit-for-purpose flexibility and delivers comprehensive insight into charge and size variants within one hour.
- Regular daily sampling of crude cell culture supernatants directly from the bioreactor builds reliable trendlines over time.
- Operators can quickly identify batch-divergent behavior using UVD to support timely process adjustments or perform deeper molecular characterization with HRAM MS.
- A standardized, switchable workflow also supports method transfer across teams and sites, reducing variability during scale-up and method transfer.
Fewer surprises, faster course corrections, and scaling operations without expert guidance are something analysts, engineers, quality control, finance, and regulatory bodies can all get behind.
Interested in using switchable 2D-LC workflows for your mAb manufacturing processes?
See real bioreactor data and step-by-step setup details in our application notes today.
- Switchable 2D-LC-UV workflows for routine monitoring
- Switchable 2D-LC-MS workflows for deeper characterizations
Figure 6. Illustration showing how switchable 2D-LC works
Frequently asked questions
Some of the most important critical quality attributes of cell culture derived samples you should monitor include mAb titer, charge and size variants, and glycosylation profiles.
2D-LC is a technique that successively uses two complementary LC modes for a multi-dimensional separation. Traditionally such systems are used for additional selectivity to help resolve complex separations or to deplete interfering matrices.
Switchable heart-cut 2D-LC workflows facilitate toggling between size and charge variant analysis of the intact mAb under native conditions — directly from cell culture samples — without reconfiguring the hardware.
UVD supports quick, efficient decisions during production progression and is ideal for monitoring well-established biosynthetic processes. HRAM-MS allows for a deep characterization and comprehensive insights into glycan profiles, modifications, and aggregates at the intact level.
Visit us on LinkedIn: #ChargeVariantAnalysis, #HRAM, #LiquidChromatography